Antioxidant and lipid supplementation improve the development of photoreceptor outer segments in pluripotent stem cell-derived retinal organoids
Author(s) -
Emma L. West,
Paromita Majumder,
Arifa Naeem,
Milan Fernando,
Michelle O’Hara-Wright,
Emily P. Lanning,
Magdalena Kloc,
Joana Ribeiro,
Patrick Ovando-Roche,
Ian O. Shum,
Neeraj Jumbu,
Robert D. Sampson,
Matthew Hayes,
James Bainbridge,
Anastasios Georgiadis,
Alexander J. Smith,
Anai Gonzalez-Cordero,
Robin R. Ali
Publication year - 2022
Publication title -
stem cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.207
H-Index - 76
ISSN - 2213-6711
DOI - 10.1016/j.stemcr.2022.02.019
Subject(s) - induced pluripotent stem cell , retinal , biology , retinitis pigmentosa , microbiology and biotechnology , organoid , retina , retinal disorder , stem cell , retinal degeneration , visual phototransduction , embryonic stem cell , neuroscience , genetics , biochemistry , gene
The generation of retinal organoids from human pluripotent stem cells (hPSC) is now a well-established process that in part recapitulates retinal development. However, hPSC-derived photoreceptors that exhibit well-organized outer segment structures have yet to be observed. To facilitate improved inherited retinal disease modeling, we determined conditions that would support outer segment development in maturing hPSC-derived photoreceptors. We established that the use of antioxidants and BSA-bound fatty acids promotes the formation of membranous outer segment-like structures. Using new protocols for hPSC-derived retinal organoid culture, we demonstrated improved outer segment formation for both rod and cone photoreceptors, including organized stacked discs. Using these enhanced conditions to generate iPSC-derived retinal organoids from patients with X-linked retinitis pigmentosa, we established robust cellular phenotypes that could be ameliorated following adeno-associated viral vector-mediated gene augmentation. These findings should aid both disease modeling and the development of therapeutic approaches for the treatment of photoreceptor disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom